{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:46:00Z","timestamp":1792802760379,"version":"4.5.0"},"reference-count":37,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1248\/bpb.b15-00331","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T22:06:27Z","timestamp":1441317987000},"page":"1700-1706","source":"Crossref","is-referenced-by-count":37,"title":["Epigallocatechin-3-gallate (EGCG) Suppresses the Trafficking of Lymphocytes to Epidermal Melanocytes <i>via<\/i> Inhibition of JAK2: Its Implication for Vitiligo Treatment"],"prefix":"10.1248","volume":"38","author":[{"given":"Weixuan","family":"Ning","sequence":"first","affiliation":[{"name":"Department of Dermatology, Guangxing Affiliated Hospital of Zhejiang Chinese Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiquan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Third People\u2019s Hospital of Hangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Dong","sequence":"additional","affiliation":[{"name":"ZJU-ENS Joint Laboratory of Medicinal Chemistry, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Third People\u2019s Hospital of Hangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Third People\u2019s Hospital of Hangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Third People\u2019s Hospital of Hangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aie","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Third People\u2019s Hospital of Hangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Bystryn JC. Immune mechanisms in vitiligo. Clin. Dermatol.<\/i>, 15<\/b>, 853\u2013861 (1997).","DOI":"10.1016\/S0738-081X(97)00126-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab. Invest.<\/i>, 80<\/b>, 1299\u20131309 (2000).","DOI":"10.1038\/labinvest.3780138"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lili Y, Yi W, Ji Y, Yue S, Weimin S, Ming L. Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo. PLoS ONE<\/i>, 7<\/b>, e37513 (2012).","DOI":"10.1371\/journal.pone.0037513"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ, Vyth-Dreese FA, Luiten RM. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J. Invest. Dermatol.<\/i>, 129<\/b>, 2220\u20132232 (2009).","DOI":"10.1038\/jid.2009.32"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ogg GS, Rod Dunbar P, Romero P, Chen JL, Cerundolo V. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J. Exp. Med.<\/i>, 188<\/b>, 1203\u20131208 (1998).","DOI":"10.1084\/jem.188.6.1203"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Shaffrali F, Gawkrodger D. Management of vitiligo. Clin. Exp. Dermatol.<\/i>, 25<\/b>, 575\u2013579 (2000).","DOI":"10.1046\/j.1365-2230.2000.00709.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kumari J. Vitiligo treated with topical clobetasol propionate. Arch. Dermatol.<\/i>, 120<\/b>, 631\u2013635 (1984).","DOI":"10.1001\/archderm.1984.01650410073019"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kalaiselvi P, Rajashree K, BharathiPriya L, Padma VV. Cytoprotective effect of epigallocatechin-3-gallate against deoxynivalenol-induced toxicity through anti-oxidative and anti-inflammatory mechanisms in HT-29 cells. Food Chem. Toxicol.<\/i>, 56<\/b>, 110\u2013118 (2013).","DOI":"10.1016\/j.fct.2013.01.042"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Van Aller GS, Carson JD, Tang W, Peng H, Zhao L, Copeland RA, Tummino PJ, Luo L. Epigallocatechingallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase\/mTOR inhibitor. Biochem. Biophys. Res. Commun.<\/i>, 406<\/b>, 194\u2013199 (2011).","DOI":"10.1016\/j.bbrc.2011.02.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Zhu Y, Wang S, Lin F, Li Q, Xu A. The therapeutic effects of EGCG on vitiligo. Fitoterapia<\/i>, 99<\/b>, 243\u2013251 (2014).","DOI":"10.1016\/j.fitote.2014.08.007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Darnell JE Jr. STATs and gene regulation. Science<\/i>, 277<\/b>, 1630\u20131635 (1997).","DOI":"10.1126\/science.277.5332.1630"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ghoreschi K, Laurence A, O\u2019Shea JJ. Janus kinases in immune cell signaling. Immunol. Rev.<\/i>, 228<\/b>, 273\u2013287 (2009).","DOI":"10.1111\/j.1600-065X.2008.00754.x"},{"key":"13","unstructured":"13) Hsu L, Armstrong AW. JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis. J Immunol Res.<\/i>, 2014<\/b>, 283617 (2014)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ortiz-Ib\u00e1\u00f1ez K, Alsina MM, Mu\u00f1oz-Santos C. Tofacitinib and other kinase inhibitors in the treatment of psoriasis. Actas Dermosifiliogr.<\/i>, 104<\/b>, 304\u2013310 (2013).","DOI":"10.1016\/j.adengl.2013.03.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Fridman JS, Scherle PA, Collins R, Burn T, Neilan CL, Hertel D, Contel N, Haley P, Thomas B, Shi J, Collier P, Rodgers JD, Shepard S, Metcalf B, Hollis G, Newton RC, Yeleswaram S, Friedman SM, Vaddi K. Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation. J. Invest. Dermatol.<\/i>, 131<\/b>, 1838\u20131844 (2011).","DOI":"10.1038\/jid.2011.140"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Chen JT, Liang JB, Chou CL, Chien MW, Shyu RC, Chou PI, Lu DW. Glucosamine sulfate inhibits TNF-alpha and IFN-gamma-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro<\/i>. Invest. Ophthalmol. Vis. Sci.<\/i>, 47<\/b>, 664\u2013672 (2006).","DOI":"10.1167\/iovs.05-1008"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Roebuck KA, Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J. Leukoc. Biol.<\/i>, 66<\/b>, 876\u2013888 (1999).","DOI":"10.1002\/jlb.66.6.876"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wang S, Zhou M, Lin F, Liu D, Hong W, Lu L, Zhu Y, Xu A. Interferon-\u03b3 induces senescence in normal human melanocytes. PLoS ONE<\/i>, 9<\/b>, e93232 (2014).","DOI":"10.1371\/journal.pone.0093232"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Chatterjee S, Eby JM, Al-Khami AA, Soloshchenko M, Kang HK, Kaur N, Naga OS, Murali A, Nishimura MI, Le Poole IC, Mehrotra S. A quantitative increase in regulatory T cells controls development of vitiligo. J. Invest. Dermatol.<\/i>, 134<\/b>, 1285\u20131294 (2014).","DOI":"10.1038\/jid.2013.540"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Shi F, Erf GF. IFN-\u03b3, IL-21, and IL-10 co-expression in evolving autoimmune vitiligo lesions of Smyth line chickens. J. Invest. Dermatol.<\/i>, 132<\/b>, 642\u2013649 (2012).","DOI":"10.1038\/jid.2011.377"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Li YL, Yu CL, Yu HS. IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes. J. Invest. Dermatol.<\/i>, 115<\/b>, 969\u2013973 (2000).","DOI":"10.1046\/j.1523-1747.2000.00130.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Harris JE, Harris TH, Weninger W, Wherry EJ, Hunter CA, Turka LA. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8T-cell accumulation in the skin. J. Invest. Dermatol.<\/i>, 132<\/b>, 1869\u20131876 (2012).","DOI":"10.1038\/jid.2011.463"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) al Badri AM, Foulis AK, Todd PM, Gariouch JJ, Gudgeon JE, Stewart DG, Gracie JA, Goudie RB. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo. J. Pathol.<\/i>, 169<\/b>, 203\u2013206 (1993).","DOI":"10.1002\/path.1711690205"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Rashighi M, Agarwal P, Richmond JM, Harris TH, Dresser K, Su MW, Zhou Y, Deng A, Hunter CA, Luster AD, Harris JE. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci. Transl. Med.<\/i>, 6<\/b>, 223ra23 (2014).","DOI":"10.1126\/scitranslmed.3007811"},{"key":"25","unstructured":"25) Crane IJ, McKillop-Smith S, Wallace CA, Lamont GR, Forrester JV. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci.<\/i>, 42<\/b>, 1547\u20131552 (2001)."},{"key":"26","unstructured":"26) Elner SG, Elner VM, Bian ZM, Lukacs NW, Kurtz RM, Strieter RM, Kunkel SL. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products. Invest. Ophthalmol. Vis. Sci.<\/i>, 38<\/b>, 446\u2013455 (1997)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Berencsi K, Rani P, Zhang T, Gross L, Mastrangelo M, Meropol NJ, Herlyn D, Somasundaram R. In vitro<\/i> migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2. J. Transl. Med.<\/i>, 9<\/b>, 33 (2011).","DOI":"10.1186\/1479-5876-9-33"},{"key":"28","unstructured":"28) Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol.<\/i>, 149<\/b>, 1\u201338 (2003)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Toosi S, Orlow SJ, Manga P. Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. J. Invest. Dermatol.<\/i>, 132<\/b>, 2601\u20132609 (2012).","DOI":"10.1038\/jid.2012.181"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Marino M, Scuderi F, Provenzano C, Scheller J, Rose-John S, Bartoccioni E. IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. J. Neuroimmunol.<\/i>, 196<\/b>, 41\u201348 (2008).","DOI":"10.1016\/j.jneuroim.2008.02.005"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Chen SC, Chang YL, Wang DL, Cheng JJ. Herbal remedy magnolol suppresses IL-6-induced STAT3 activation and gene expression in endothelial cells. Br. J. Pharmacol.<\/i>, 148<\/b>, 226\u2013232 (2006).","DOI":"10.1038\/sj.bjp.0706647"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Gilhar A, Aizen E, Ohana N, Etzioni A. Vitiliginous vs.<\/i> pigmented skin response to intradermal administration of interferon gamma. Arch. Dermatol.<\/i>, 129<\/b>, 600\u2013604 (1993).","DOI":"10.1001\/archderm.1993.01680260070009"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Lebedeva T, Dustin ML, Sykulev Y. ICAM-1 co-stimulates target cells to facilitate antigen presentation. Curr. Opin. Immunol.<\/i>, 17<\/b>, 251\u2013258 (2005).","DOI":"10.1016\/j.coi.2005.04.008"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Norris DA. Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. J. Invest. Dermatol.<\/i>, 95<\/b> (Suppl.), 111S\u2013120S (1990).","DOI":"10.1111\/1523-1747.ep12874977"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Anikeeva N, Somersalo K, Sims TN, Thomas VK, Dustin ML, Sykulev Y. Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 102<\/b>, 6437\u20136442 (2005).","DOI":"10.1073\/pnas.0502467102"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Koneru M, Monu N, Schaer D, Barletta J, Frey AB. Defective adhesion in tumor infiltrating CD8+ T cells. J. Immunol.<\/i>, 176<\/b>, 6103\u20136111 (2006).","DOI":"10.4049\/jimmunol.176.10.6103"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Hong WS, Hu DN, Qian GP, McCormick SA, Xu AE. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation. Br. J. Dermatol.<\/i>, 165<\/b>, 520\u2013525 (2011).","DOI":"10.1111\/j.1365-2133.2011.10398.x"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/38\/11\/38_b15-00331\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T05:10:03Z","timestamp":1567141803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/38\/11\/38_b15-00331\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b15-00331","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}